These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 2878967)
21. Comparison of dot-ELISA and standard ELISA for detection of Neisseria meningitidis outer membrane complex-specific antibodies. Belo EF; Farhat CK; Gaspari EN Braz J Infect Dis; 2010; 14(1):35-40. PubMed ID: 20428652 [TBL] [Abstract][Full Text] [Related]
22. Phenotypic variants of meningococci and their potential in phagocytic interactions: the influence of opacity proteins, pili, PilC and surface sialic acids. McNeil G; Virji M Microb Pathog; 1997 May; 22(5):295-304. PubMed ID: 9160299 [TBL] [Abstract][Full Text] [Related]
23. Epitopes of serogroup B Neisseria meningitidis analysed in vitro and directly from cerebrospinal fluid. Wall RA; Davies HA; Borriello SP FEMS Microbiol Lett; 1989 Nov; 53(1-2):129-35. PubMed ID: 2482220 [TBL] [Abstract][Full Text] [Related]
24. Antibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen. Harthug S; Rosenqvist E; Høiby EA; Gedde-Dahl TW; Frøholm LO J Clin Microbiol; 1986 Dec; 24(6):947-53. PubMed ID: 3097068 [TBL] [Abstract][Full Text] [Related]
25. Human bactericidal antibody response to meningococcal outer membrane protein vaccines. Zollinger WD; Boslego J; Frøholm LO; Ray JS; Moran EE; Brandt BL Antonie Van Leeuwenhoek; 1987; 53(6):403-11. PubMed ID: 3130779 [TBL] [Abstract][Full Text] [Related]
26. Human antibody response to the 70-Kd common neisserial antigen in patients and carriers of meningococci or non-pathogenic Neisseria. Aoun L; Lavitola A; Aubert G; Prère MF; Cremieux AC; Martin PM Ann Inst Pasteur Microbiol; 1988; 139(2):203-12. PubMed ID: 3136782 [TBL] [Abstract][Full Text] [Related]
27. Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing. Hamadeh RM; Estabrook MM; Zhou P; Jarvis GA; Griffiss JM Infect Immun; 1995 Dec; 63(12):4900-6. PubMed ID: 7591153 [TBL] [Abstract][Full Text] [Related]
28. A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. Achtman M; Kusecek B; Morelli G; Eickmann K; Wang JF; Crowe B; Wall RA; Hassan-King M; Moore PS; Zollinger W J Infect Dis; 1992 Jan; 165(1):53-68. PubMed ID: 1370175 [TBL] [Abstract][Full Text] [Related]
29. Role of horizontal genetic exchange in the antigenic variation of the class 1 outer membrane protein of Neisseria meningitidis. Feavers IM; Heath AB; Bygraves JA; Maiden MC Mol Microbiol; 1992 Feb; 6(4):489-95. PubMed ID: 1560777 [TBL] [Abstract][Full Text] [Related]
31. Multiple gonococcal pilin antigenic variants are produced during experimental human infections. Seifert HS; Wright CJ; Jerse AE; Cohen MS; Cannon JG J Clin Invest; 1994 Jun; 93(6):2744-9. PubMed ID: 7911129 [TBL] [Abstract][Full Text] [Related]
32. Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections. Black JR; Black WJ; Cannon JG J Infect Dis; 1985 Apr; 151(4):650-7. PubMed ID: 3919117 [TBL] [Abstract][Full Text] [Related]
33. Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Virji M; Makepeace K; Peak IR; Ferguson DJ; Jennings MP; Moxon ER Mol Microbiol; 1995 Nov; 18(4):741-54. PubMed ID: 8817495 [TBL] [Abstract][Full Text] [Related]
34. Testing the vaccine potential of PilV, PilX and ComP, minor subunits of Neisseria meningitidis type IV pili. Cehovin A; Kroll JS; Pelicic V Vaccine; 2011 Sep; 29(40):6858-65. PubMed ID: 21803096 [TBL] [Abstract][Full Text] [Related]
35. Understanding the structure and antigenicity of gonococcal pili. Getzoff ED; Parge HE; McRee DE; Tainer JA Rev Infect Dis; 1988; 10 Suppl 2():S296-9. PubMed ID: 2903537 [TBL] [Abstract][Full Text] [Related]
36. Serum antibodies to cross-reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease. Maeland JA; Wedege E APMIS; 1989 Sep; 97(9):774-80. PubMed ID: 2506916 [TBL] [Abstract][Full Text] [Related]
37. Interactions of Neisseria meningitidis with human monocytes. McNeil G; Virji M; Moxon ER Microb Pathog; 1994 Feb; 16(2):153-63. PubMed ID: 7913984 [TBL] [Abstract][Full Text] [Related]
38. Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis. Marzoa J; Sánchez S; Costoya L; Diéguez-Casal E; Freixeiro P; Brookes C; Allen L; Taylor S; Gorringe AR; Ferreirós CM; Criado MT Vaccine; 2012 Mar; 30(13):2387-95. PubMed ID: 21911024 [TBL] [Abstract][Full Text] [Related]
39. Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae. Sparling PF; Cannon JG; So M J Infect Dis; 1986 Feb; 153(2):196-201. PubMed ID: 2418125 [No Abstract] [Full Text] [Related]
40. Neisseria proteomics for antigen discovery and vaccine development. Christodoulides M Expert Rev Proteomics; 2014 Oct; 11(5):573-91. PubMed ID: 25017717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]